High Mobility Group Box 3 (HMGB3) Peptid
Kurzübersicht für High Mobility Group Box 3 (HMGB3) Peptid (ABIN8102518)
Target
Quelle
Applikation
-
-
Verwendungszweck
- HMGB3 Peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-HMGB3 antibody ( ARP35766_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- HMGB3 (High Mobility Group Box 3 (HMGB3))
-
Hintergrund
-
Background Information: The human HMG2a gene is transcribed mainly in the placenta. HMG2a encodes a protein which is part of the high mobility group (HMG) family. Members of this family are ubiquitously expressed and facilitate the formation of nucleoprotein complexes where the DNA is sharply bent.
Alternative Symbols: HMG4, HMG-4, HMG2A, HMG-2a
-
Molekulargewicht
- 23kDa
-
Gen-ID
- 3149
-
NCBI Accession
- NP_005333
-
UniProt
- O15347
Target
-